UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 22.862

Sortiert nach

1036 Comparison of gemcitaibne or liposomal doxorubicin in patients with high grade serous ovarian cancer with partial platinum response

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A331-A332

2023

Link zum Volltext

Verfügbarkeit prüfen

1068 Obturator nerve section in laparoscopic pelvic lymphadenectomy performed in grade 3 endometrioid adenocarcinoma

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A46-A46

2023

Link zum Volltext

Verfügbarkeit prüfen

72 Ovarian cancer audit of a UK tertiary centre over the past 3 years

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A244-A244

2023

Link zum Volltext

Verfügbarkeit prüfen

58 Laparoscopic sentinel lymph node mapping with indocyanine green in endometrial cancer

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A129-A130

2023

Link zum Volltext

Verfügbarkeit prüfen

669 Adenocarcinoma of the uterine cervix: clinicopathological features of an uncommon entity

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A88-A88

2023

Link zum Volltext

Verfügbarkeit prüfen

71 Integrated multi-omic and clinicopathological analysis of high-grade serous ovarian cancer in BRCA1/2 mutated patients with poor survival: identification of predictive biomarkers for personalized treatment

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A32-A33

2023

Link zum Volltext

Verfügbarkeit prüfen

514 Potential targeted therapies for ovarian cancer beyond PARP inhibitors (review)

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A286-A287

2023

Link zum Volltext

Verfügbarkeit prüfen

947 Immunohistochemical markers of endometrial cancer of different morfological forms

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A191-A192

2023

Link zum Volltext

Verfügbarkeit prüfen

811 Ovarian tumor organotypic slices cultures for functional drug screening (TOSCA)

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A417-A417

2023

Link zum Volltext

Verfügbarkeit prüfen

548 Is still there a place for primary pelvic exenterations, mainly in patients with fistulas?

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A357-A358

2023

Link zum Volltext

Verfügbarkeit prüfen

714 Breast cancer in elderly women: clinicopathological and prognostic features

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A121-A122

2023

Link zum Volltext

Verfügbarkeit prüfen

863 The role of pegylated liposomal doxorubicin and weekly paclitaxel with or without bevacizumab in prolonging the platinum-free interval in epithelial ovarian cancer

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A317-A317

2023

Link zum Volltext

Verfügbarkeit prüfen

463 Cancer survivors’ perceived value of sexual counseling: possibilities and barriers. – A qualitative interview study of cancer survivors with pelvic cance

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A356-A357

2023

Link zum Volltext

Verfügbarkeit prüfen

471 PARP-inhibitors can be applied together with tumor treating fields (TTFields) to prolong survival in an ovarian cancer mouse model

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A282-A282

2023

Link zum Volltext

Verfügbarkeit prüfen

440 Vibrators, dilators, lubricants and other sexual AIDS for patients with sexual late effects of pelvic cancer

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A356-A356

2023

Link zum Volltext

Verfügbarkeit prüfen

985 How long should patients stay in hospital after minimally invasive hysterectomy?

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A231-A232

2023

Link zum Volltext

Verfügbarkeit prüfen

487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A416-A416

2023

Link zum Volltext

Verfügbarkeit prüfen

583 Survival of patients with brain metastases from ovarian cancer: retrospective monocentric study

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A290-A291

2023

Link zum Volltext

Verfügbarkeit prüfen

31 Targeting PI3K increases the efficacy of anti-PD-1 antibody in cervical cancer

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A56-A56

2023

Link zum Volltext

Verfügbarkeit prüfen

710 Potential prognostic role of somatic mutations in set of cancer susceptibility genes and poly ADP-ribose polymerase (PARP) expression in surface epithelial ovarian carcinoma cases: a follow-up study from Pakistan

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A301-A302

2023

Link zum Volltext

Verfügbarkeit prüfen

510 Niraparib outcomes in brca wild-type platinum sensitive recurrent ovarian cancer: a comparison of real-world data to the nova trial

International journal of gynecological cancer, 2020, Vol.30 (Suppl 4), p.A85-A86

2020

Link zum Volltext

Verfügbarkeit prüfen

94 Bilateral breast cancer radio-induced after prophylactic bilateral pulmonary irradiation: about 2 cases

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A397-A397

2023

Link zum Volltext

Verfügbarkeit prüfen

701 Secondary acute myeloid leukaemia in a patient with BRAC2-associated breast and ovarian cancer

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A300-A301

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical presentation and treatment outcome in two patients with intravascular large B cell lymphoma

European Journal of Cancer, 2023, Vol.190, p.113095, Article 113095

2023

Link zum Volltext

Verfügbarkeit prüfen

63 Central nervous system metastasis in gynecologic cancers: seeking the prognostic factors

International journal of gynecological cancer, 2023, Vol.33 (Suppl 3), p.A242-A243

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 22.862

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

SpracheCroatian

SprachePersisch

PublikationsformTagungsberichte

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.712)
Mit Volltextzugriff
(14.063)

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Cancer
(10.977)
Science & Technology
(9.465)
Technology
(9.200)
Engineering
(6.084)
Breast Cancer
(5.581)
Computer Science
(4.775)
Engineering, Electrical & Electronic
(4.218)
Feature Extraction
(3.102)
Tumors
(3.088)
Engineering, Biomedical
(2.632)
Image Segmentation
(2.527)
Machine Learning
(2.507)
Life Sciences & Biomedicine
(2.380)
Computer Science, Artificial Intelligence
(2.261)
Deep Learning
(2.201)
Support Vector Machines
(1.856)
Training
(1.852)
Computer Science, Theory & Methods
(1.673)
Classification
(1.569)
Neural Networks
(1.441)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IEEE Xplore Digital Library
(17.968)
IngentaConnect
(1.875)
EZB Electronic Journals Library
(963)
BMJ Journals
(808)
MEDLINE
(716)
Springer Book Series
(699)
ACM Digital Library
(597)
Ovid SocietyJournals and Single Titles
(590)
Wiley Online Library
(526)
IngentaConnect Journals
(410)
Thieme Connect Journals
(318)
SpringerLink
(303)
eBooks on EBSCOhost
(241)
Ebook Central Perpetual and DDA
(238)
Sociological Abstracts
(113)
NUS Single-Journal Subscriptions
(107)
Elsevier ScienceDirect Journals Complete
(101)
SAGE Journals
(66)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(27)
Wiley Online Library
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(728)
... seit 30 Tagen
(140)

Menü

Weitere Dienste

Einstellungen

1036 Comparison of gemcitaibne or liposomal doxorubicin in patients with high grade serous ovarian cancer with partial platinum response

1068 Obturator nerve section in laparoscopic pelvic lymphadenectomy performed in grade 3 endometrioid adenocarcinoma

72 Ovarian cancer audit of a UK tertiary centre over the past 3 years

58 Laparoscopic sentinel lymph node mapping with indocyanine green in endometrial cancer

669 Adenocarcinoma of the uterine cervix: clinicopathological features of an uncommon entity

71 Integrated multi-omic and clinicopathological analysis of high-grade serous ovarian cancer in BRCA1/2 mutated patients with poor survival: identification of predictive biomarkers for personalized treatment

514 Potential targeted therapies for ovarian cancer beyond PARP inhibitors (review)

947 Immunohistochemical markers of endometrial cancer of different morfological forms

811 Ovarian tumor organotypic slices cultures for functional drug screening (TOSCA)

548 Is still there a place for primary pelvic exenterations, mainly in patients with fistulas?

714 Breast cancer in elderly women: clinicopathological and prognostic features

863 The role of pegylated liposomal doxorubicin and weekly paclitaxel with or without bevacizumab in prolonging the platinum-free interval in epithelial ovarian cancer

463 Cancer survivors’ perceived value of sexual counseling: possibilities and barriers. – A qualitative interview study of cancer survivors with pelvic cance

471 PARP-inhibitors can be applied together with tumor treating fields (TTFields) to prolong survival in an ovarian cancer mouse model

440 Vibrators, dilators, lubricants and other sexual AIDS for patients with sexual late effects of pelvic cancer

985 How long should patients stay in hospital after minimally invasive hysterectomy?

487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)

583 Survival of patients with brain metastases from ovarian cancer: retrospective monocentric study

31 Targeting PI3K increases the efficacy of anti-PD-1 antibody in cervical cancer

710 Potential prognostic role of somatic mutations in set of cancer susceptibility genes and poly ADP-ribose polymerase (PARP) expression in surface epithelial ovarian carcinoma cases: a follow-up study from Pakistan

510 Niraparib outcomes in brca wild-type platinum sensitive recurrent ovarian cancer: a comparison of real-world data to the nova trial

94 Bilateral breast cancer radio-induced after prophylactic bilateral pulmonary irradiation: about 2 cases

701 Secondary acute myeloid leukaemia in a patient with BRAC2-associated breast and ovarian cancer

Clinical presentation and treatment outcome in two patients with intravascular large B cell lymphoma

63 Central nervous system metastasis in gynecologic cancers: seeking the prognostic factors

Aktive Filter

Suchergebnisse filtern